Abstract: Disclosed is solid electrolyte containing gallium and tellurium-doped lithium lanthanum zirconium oxide (LLZO), a method for preparing the same, and an all-solid-state battery including the same. The all-solid-state battery including the solid electrolyte containing gallium and tellurium-doped lithium lanthanum zirconium oxide (LLZO) exhibits excellent electrochemical performance.

Abstract: Disclosed are a carbon dioxide utilization system capable of producing electricity, hydrogen, and bicarbonate by utilizing carbon dioxide, which is a greenhouse gas, through a spontaneous electrochemical reaction without a separate external power source, and producing magnesium hydrogen carbonate by reacting the hydrogen carbonate ions with magnesium ions generated at an anode.

Abstract: Disclosed is an exhaust gas purification system, including: a cathode unit including a first accommodation space, a first aqueous solution, and a cathode at least partially submerged in the first aqueous solution; an anode unit including a second accommodation space, a second aqueous solution which is basic, and a metal anode at least partially submerged in the second aqueous solution; and a connection unit configured to connect the cathode unit and the anode unit. The anode is made of aluminum (Al) or zinc (Zn), a gas containing nitrogen oxide (NOx) is injected into the first aqueous solution, the nitrogen oxide injected into the first aqueous solution reacts with water to produce nitric acid (HNO3), the nitric acid supplies hydrogen ions, and the hydrogen ions and electrons of the cathode react to produce hydrogen.

Abstract: The present invention relates to recombinant adenoviruses expressing interleukin-18 protein, and gene therapy using them. More particularly, the invention provides recombinant adenoviruses Ad.promIL-18, Ad.GMmIL-18, Ad.prohIL-18, Ad.hIL-18CPP32- and Ad.preprotrypsin.hIL-18CPP32- which are effectively capable of treating a variety of cancer cells by promoting and enhancing an immune response in vivo.

Abstract: The present invention relates to a diagnosis method of cancer using SYG972 gene and to the genomic DNA and to a promoter regulating transcription of the gene. Expression of SYG972 gene is greatly reduced in breast cancer cells compared to normal breast cells. Therefore the present invention provides a method of diagnosis method by using the gene of the present invention or its fragments as a probe. SYG972 genomic according to the present invention is composed of 4 exons and 3 introns. Promoter is 3 kb long from the transcription initiating site in the 5′ direction. SYG972 genomic DNA and promoter can be used to design and screen drugs to promote or to inhibit apoptosis and differentiation of cells, especially to screen drugs to treat cancer, a disease wherein cell growth and differentiation is abnormal.

Abstract: The present invention relates to a vector comprising P972 (also referred to as Gadd45&ggr;, CR6 or OIG37) gene known as a gene producing a cell growth-inhibiting protein for the treatment of cancers, an recombinant adenovirus that encodes P972 gene in the cell, a method of producing the above adenovirus and a method for the treatment of cancers by using the above vector or adenovirus. The recombinant adenovirus of the present invention can be used in the treatment of various cancers including cervical cancer, breast cancerand colon cancer.

Abstract: The present invention relates to a diagnosis method of cancer using SYG972 gene and to the genomic DNA and to a promoter regulating transcription of the gene. Expression of SYG972 gene is greatly reduced in breast cancer cells compared to normal breast cells. Therefore the present invention provides a method of diagnosis method by using the gene of the present invention or its fragments as a probe. SYG972 genomic according to the present invention is composed of 4 axons and 3 introns. Promoter is 3 kb long from the transcription initiating site in the 5′ direction. SYG972 genomic DNA and promoter can be used to design and screen drugs to promote or to inhibit apoptosis and differentiation of cells, especially to screen drugs to treat cancer, a disease wherein cell growth and differentiation is abnormal.